Atreca Inc. (BCEL) PT Lowered to $17 at Brookline Capital Markets, Following Clinical Business Update

July 29, 2021 3:58 PM EDT
Get Alerts BCEL Hot Sheet
Price: $6.66 --0%

Rating Summary:
    9 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 6 | Down: 10 | New: 28
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Brookline Capital Markets analyst Kumaraguru Raja lowered the price target on Atreca Inc. (NASDAQ: BCEL) to $17.00 (from $31.00) while maintaining a Buy rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change